Related Experiment Video

Updated: Jun 14, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients

O Slaby1, R Lakomy, P Fadrus

  • 1Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic. slaby@mou.cz

Neoplasma
|April 1, 2010
PubMed

Insights

MicroRNAs regulate gene expression. This study found miR-181b and miR-181c down-regulation in glioblastoma patients responding to chemoradiotherapy with temozolomide (RT/TMZ), suggesting their potential as predictive biomarkers.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Altered miRNA expression is implicated in glioblastoma development.
  • MGMT promoter methylation is a predictive marker for glioblastoma treatment response.

Purpose of the Study:

  • To investigate the expression levels of specific microRNAs in glioblastoma.
  • To explore the correlation between miRNA expression, MGMT methylation, and response to chemoradiotherapy with temozolomide (RT/TMZ).
  • To identify potential miRNA biomarkers for predicting RT/TMZ treatment efficacy in glioblastoma.

Main Methods:

  • Real-time PCR was used to quantify miRNA expression in 22 primary glioblastomas and 6 adult brain tissue specimens.
  • Methylation-specific real-time PCR assessed MGMT promoter methylation status.
  • Expression data were analyzed in correlation with clinical response to RT/TMZ.

Main Results:

  • Several microRNAs (miR-221, miR-222, miR-181b, miR-181c, miR-128a) were significantly down-regulated in glioblastomas.
  • miR-21 expression was significantly up-regulated in glioblastomas.
  • MGMT methylation status did not correlate with RT/TMZ response.
  • Down-regulation of miR-181b and miR-181c was significantly associated with response to RT/TMZ compared to progressive disease.

Conclusions:

  • miR-181b and miR-181c expression levels may serve as predictive biomarkers for response to chemoradiotherapy with temozolomide in glioblastoma patients.
  • These findings highlight the potential role of specific microRNAs in guiding glioblastoma treatment decisions.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...